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Abstract
Background and Objective: Barrett’s esophagus (BE) is characterized by the transition of squamous epithelium into
columnar epithelium with intestinal metaplasia. The increased number and types of immune cells in BE have been indicated
to be due to a Th2-type inflammatory process. We tested the alternative hypothesis that the abundance of T-cells in BE is
caused by a homing mechanism that is found in the duodenum.
Patients and Methods: Biopsies from BE and duodenal tissue from 30 BE patients and duodenal tissue from 18 controls
were characterized by immmunohistochemistry for the presence of T-cells and eosinophils(eos). Ex vivo expanded T-cells
were further phenotyped by multicolor analysis using flowcytometry.
Results: The high percentage of CD4
+-T cells (6963% (mean6SEM/n=17, by flowcytometry)), measured by flowcytometry
and immunohistochemistry, and the presence of non-activated eosinophils found in BE by immunohistochemical staining,
were not different from that found in duodenal tissue. Expanded lymphocytes from these tissues had a similar phenotype,
characterized by a comparable but low percentage of aE(CD103) positive CD4
+cells (4465% in BE, 4364% in duodenum of
BE and 3467% in duodenum of controls) and a similar percentage of granzyme-B
+CD8
+ cells(4465% in BE, 3366% in
duodenum of BE and 3667% in duodenum of controls). In addition, a similar percentage of a4b7
+ T-lymphocytes (6365%
in BE, 5865% in duodenum of BE and 6268% in duodenum of controls) was found. Finally, mRNA expression of the ligand
for a4b7, MAdCAM-1, was also similar in BE and duodenal tissue. No evidence for a Th2-response was found as almost no IL-
4
+-T-cells were seen.
Conclusion: The immune cell composition (lymphocytes and eosinophils) and expression of intestinal adhesion molecule
MAdCAM-1 is similar in BE and duodenum. This supports the hypothesis that homing of lymphocytes to BE tissue is mainly
caused by intestinal homing signals rather than to an active inflammatory response.
Citation: Lind A, Siersema PD, Kusters JG, Van der Linden JAM, Knol EF, et al. (2012) The Immune Cell Composition in Barrett’s Metaplastic Tissue Resembles That
in Normal Duodenal Tissue. PLoS ONE 7(4): e33899. doi:10.1371/journal.pone.0033899
Editor: Stefan Bereswill, Charite ´-University Medicine Berlin, Germany
Received December 9, 2011; Accepted February 19, 2012; Published April 3, 2012
Copyright:  2012 Lind et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by Dutch Digestive Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: L.Koenderman@umcutrecht.nl
Introduction
Barrett’s esophagus (BE) is a risk factor for the development of
esophageal adenocarcinoma (EAC) with an incidence rate of
around 1 in 200 patient years of follow-up in BE [1]. The
incidence EAC continues to increase and is currently the fastest
rising malignancy in the Western world [2].
BE is characterized by the presence of columnar epithelium of
the intestinal type, which is mostly induced by gastroesophageal
reflux [3]. The transformation of the normally present squamous
lining in the esophagus into the intestinal-type columnar lining in
BE is accompanied by the presence of high numbers of immune
cells [2,4–7]. This increase in immune cells is also observed in
reflux esophagitis (RE), which most likely precedes the develop-
ment of BE [2,4,8]. Currently, not much is known about the
distribution of immune cells in RE in relation to the induction of
BE. The presence of a chronic inflammatory reaction has,
however, been associated with an increased risk of developing
BE and progression towards neoplastic changes in this premalig-
nant disorder [9,10].
While no detailed studies have been performed on the
distribution of immune cells in BE, earlier studies have suggested
that the presence of T-cells seen in BE tissue is indicative of a Th2-
response [7,11]. Fitzgerald et al showed an increased expression of
IL-4 mRNA in BE-tissue, which was four-fold higher compared to
RE [11]. They also found indications for a Th1 response in
esophageal tissue of RE as suggested by an upregulation of IFN-c
mRNA compared to BE (3–10-fold increase). These data were
supported by immunohistochemical evidence showing enhanced
staining for IL-4 and IFN-c in frozen BE and RE sections,
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e33899respectively [11]. In this study, esophageal metaplastic (intestinal
type) tissue was compared with esophageal squamous epithelium
of RE patients and controls.
Until now, BE has not been compared with another type of
columnar epithelium, such as duodenum. This may be relevant as
even in the absence of an ongoing inflammatory response the
normal gut tissue is relatively rich in Th2 type T-lymphocytes [12].
These observations prompted us to investigate an alternative
hypothesis, i.e., that immune cells in BE tissue are in fact present
as a consequence of intestinal-type of columnar epithelium in BE
rather than being a result of an active inflammatory response.
Previous studies on the immune cell composition in BE have
mainly focused on PCR results of whole biopsies or immunohis-
tochemistry on BE sections due to the relatively small amount of
biopsy material that can be obtained from patients [7,11,13]. The
main drawback of immunohistochemistry is; however, that a
simultaneous analysis of T-cells subsets or markers on these cells in
a single slide is not possible. Recently, Clark et al reported a
method which allowed immunophenotyping of T-cells cultured
from small skin biopsies [14]. This technique uses a three-
dimensional growth matrix (collagen-coated carbon matrix) on top
of which a small skin biopsy is placed. Under these conditions,
fibroblasts can grow into the matrix, while T-cells detach from the
matrix and proliferate in the culture medium. T-cells were found
to expand at least 10-fold and various T cell populations,
particularly those that were positive for skin-homing chemokine
receptors, were detected. This method provides an opportunity to
amplify the numbers of various T-cell populations in biopsies from
the esophagus and allowed multicolor analysis and functional
experiments with T-cells.
In this study, we therefore performed in vitro expansion of T-cells
from biopsies of BE and duodenal tissue from BE patients and
duodenal tissue in order to allow us to analyse T-cell (sub)
population in these tissues in more detail.
Results
Absence of activated eosinophils in BE and duodenum
Immunohistochemical staining of the biopsies for MBP was
used to determine the presence of eosinophils. Twelve BE and 6
duodenal biopsies were compared. The number of eosinophils in
lamina propria (LP) and epithelium were determined separately.
LP and epithelium of BE biopsies were characterised by the
presence of non-activated eosinophils (normal round cells with
absence of free granules), but contained significantly lower number
of eosinophils compared to LP (p,0.0009) and epithelium
(p,0.002) of duodenum (Figure 1.) Only in 1/12 BE biopsies,
free eosinophil granules were observed.
High numbers of CD4
+- cells in the lamina propria of BE
and duodenum
Immunohistochemical staining for CD3, CD4 and CD8 was
performed to characterise lymphocytes in BE and duodenum of
controls. In duodenum high numbers of CD3
+ cells were found
(3365610
3 cells/mm
2 in LP and 1564610
3 cells/mm
2 in
epithelium). Significantly fewer CD3
+ cells were found in BE
(1263610
3 cells/mm
2 in LP (p,0.05) and 560.7610
3 cells/mm
2
in epithelium (p=0.05)) (Figure 2, panels A–C). CD8
+-counts were
low in LP of BE (361610
3 cells/mm
2). The CD8
+-count was
relatively high in epithelium of BE (260.5610
3 cells/mm
2) and in
epithelium of duodenum (1164610
3 cells/mm
2) (Figure 2, panels
B and E).
The interpretation of data regarding CD4
+-cells in tissue is
complex as part of the CD4
+-cells are monocytes. Analysis of
double stained (for CD3
+CD4
+-cells) paraffin embedded tissue did
not result in interpretable results (not shown). As a result, the
CD4
+-T-cell count was estimated by subtracting the CD8
+-cell
count from the CD3
+-cell count (=total T-cells). The corrected
CD3
+CD4
+ count in the duodenum was 562610
3 cells/mm
2 in
the epithelium and 2062610
3 cells/mm
2 in LP. The corrected
CD3
+CD4
+-count in BE was 260.4610
3 cells/mm
2 in epithelium
and 662610
3 cells/mm
2 in LP of BE (p,0.01).
Comparable proportions of CD3
+CD4
+ T-cells in BE and
duodenum from BE patients and controls
As immunophenotyping of tissue T-cells by immunohistochem-
istry only allows a limited characterization of these cells, we
analysed these cells in more detail by FACS.
From five patients we obtained paired biopsies for collagenase
treatment and ex vivo culture for 14 days. T-cells were directly
isolated from the tissue after collagenase treatment of 10 biopsies
and the phenotypes were compared with ex vivo expanded T-cells
of the same patients by FACS. The mean percentage of
CD3
+CD4
+-cells in collagenated BE biopsies was 6468% (of all
CD3
+ cells), which was similar as found at day 14 of culture
(p=0.7) (Figure 3A). In one patient, sufficient material was
obtained (biopsies for collagenase and T-cell culture) to follow the
proportion of CD3
+CD4
+-cells at different time points. The
proportion of CD3
+CD4
+-cells on day 0, 7 days and 14 days of
culture was similar (73%, 65% and 72%, respectively).
Figure 1. Similar morphology of eosinophils in Barrett’s
esophagus (BE) and duodenum. Immunohistochemical staining
with anti-MBP (eosinophil marker) of duodenum from 6 controls (black
bars, panel A) and BE biopsies from 12 BE patients (light grey bars,
panel B). Eosinophils were counted in lamina propria and intestinal
epithelium separately. DUO: duodenum, LP: lamina propria. Each bar
represents mean values6SEM and expressed as MBP-positive cells/mm
2
(** p,0.005, *** p,0.0005).
doi:10.1371/journal.pone.0033899.g001
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weeks of culture. The proportion of CD3
+CD4
+ (of all CD3
+ cells)
in duodenum of controls (6667%) and duodenum of BE patients
(6664%) was similar (Figure 3B). In addition, the proportion of
CD3
+CD4
+-cells in cultures of biopsies from BE (6963%) and
duodenum from BE patients was also similar (Figure 3B). CD4
+
and CD8
+-cells from all ex vivo cultures were predominantly
memory T-cells (CD45RO
+) (9962%). CD4
+ cells from collage-
nated biopsies were found to be for 95% CD45RO
+ and CD8
+
cells for 85% CD45RO
+.
Similar proportions of CD4
+CD103
+- cells in BE and
duodenum from BE patients and controls
CD103 (aE) is a subunit of the intraepithelial integrin aEb7 and
is present on T-cells with an immunosuppressive phenotype [15].
Duodenum of controls and BE had a similar proportion of
CD4
+CD103
+ cells (3467% and 4364% of CD3
+CD4
+ cells,
respectively) (Figure 4). Ex vivo cultures of BE had a similar
proportion of CD4
+CD103
+ (4464%) compared to cultures of
duodenum from controls and BE (Figure 4).
Similar proportions of CD8
+Granzyme B
high- cells in BE
and duodenum from BE patients and controls
To further phenotype CD8
+-cells, intracellular granzyme B-
staining in lymphocytes cultured from ex vivo biopsies was performed.
The proportion of CD8
+Granzyme B
high-cells (of all CD8
+-cells) in
duodenum of controls was 3766%, which was similar to duodenum
of BE patients (3565%) (Figure 5). The proportion of CD8
+Granzy-
meB
high in ex vivo cultures of BE was 4665%, which was not
significantly different from ex vivo cultures of duodenum (Figure 5).
Figure 2. Immunohistochemical analysis of inflammatory cells in BE and duodenum. Panels A–C Barrett’s esophagus (BE).
Immunohistochemical staining for CD3
+(panel A), CD8
+(panel B) and CD4
+-cells (panel C) was performed in BE biopsies from 6 BE patients. Cells were
counted in lamina propria (LP) and epithelium separately (light grey bars, panels A and B). Each bar represents mean value6SEM and the numbers of
CD3
+, CD4
+- or CD8
+ are expressed as cells/mm
2(n=6). Panels D–F Duodenum. Immunohistochemical staining for CD3
+(panel D), CD8
+ (panel E)
and CD4
+-cells (panel F) was performed in duodenal biopsies from 5 controls. Cells were counted in lamina propria (LP) and epithelium separately
(black bars, panels A and B).Each bar represents mean value6SEM, and the numbers of CD3
+, CD4
+- or CD8
+-are expressed as cells/mm
2 (*p,0.05,
** p,0.005, ***p,0.0005, ns not significant) (n=5).
doi:10.1371/journal.pone.0033899.g002
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Intracellular staining for IFN- c and IL-4 was performed after
21 days of culture (to obtain sufficient number of cells) to evaluate
the presence of effector Th2-cells in BE. The analysis was
performed on T-cells from BE and duodenum from 6 BE patients
and duodenum from 4 controls. T-cells from BE were char-
acterised by a positive staining pattern for IFN-c in CD4
+ (2069%
cells) and CD8
+-cells (66613%) (Figure 6 A+B), which was similar
to T-cells from duodenum of BE (CD4
+-cells (27610%) and
CD8
+-cells (54611%))(Figure 6 A+B). There was no difference
between duodenum of controls and BE in expression of IFN-c on
Figure 3. Similar percentage of CD3
+CD4
+-cells in BE and duodenal ex vivo cultures. (A) Comparison of the percentage of CD3
+CD4
+-
cells in collagenated BE biopsies and ex vivo expanded T-cells. The percentage of CD3
+CD4
+-cells was determined in paired biopsies from 5
BE patients treated by either collagenase or used for ex vivo expansion. Each bar represents the mean value6SEM of the percentage of CD3
+CD4
+-
cells in the CD3
+population (light grey bar: BE T-cells expanded for 14 days ex vivo, light grey with stripes: T-cells from collagenated BE biopsies). (B)
Percentage of CD3
+CD4
+-cells in ex vivo cultures of BE and duodenum. The percentage of CD3
+CD4
+-cells from ex vivo cultures of 17 BE
segments and 15 duodenal biopsies from 17 BE patients (DUO BE) and 11 duodenal biopsies from 11 controls (DUO control) was determined by
flowcytometry. Each bar represents the mean value6SEM of the percentage of CD3
+CD4
+-cells in the CD3
+ population (black bar: DUO control, dark
grey bar: DUO BE, light grey bar: BE) (ns not significant).
doi:10.1371/journal.pone.0033899.g003
Figure 4. Low percentage of CD4
+CD103
+-cells in ex-vivo
cultures of BE and duodenal tissue. The percentage of CD4
+
CD103
+-cells in ex vivo cultures from 14 BE segments and 13 duodenal
tissues from 14 BE patients (DUO BE) and 9 duodenal tissues from 9
controls (DUO control) was determined by flowcytometry (ns not
significant). Each bar represents mean value6SEM, percentage of
CD4
+CD103
+-cells in the CD3
+CD4
+-cells population, (black bar:
DUO control, dark grey bar: DUO BE, light grey bar: BE).
doi:10.1371/journal.pone.0033899.g004
Figure 5. High percentage of CD8
+Granzyme B
high cells in ex
vivo cultures of BE and duodenal tissue. The percentage of
Granzyme B
high -cells (from CD8
+ cells) was measured by an
intracellular FACS-staining in ex vivo cultures of 16 BE segments and
14 duodenal tissues from 16 BE patients (DUO BE) and duodenum from
11 controls (DUO controls). Each bar represents mean value6SEM of
the percentage CD8
+Granzyme B
high cells in the CD3
+CD8
+
population (black bar: DUO control, dark grey bar: DUO BE, light grey
bar: BE) (ns not significant).
doi:10.1371/journal.pone.0033899.g005
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+-cells (40610% in duodenum of controls, p=0.9 vs
duodenum of BE) and CD8
+-cells (47612%, p=0.6)(Figure 6
C+D). We were also not able to detect IL-4 in CD4
+ and CD8
+-
cells in ex vivo cultures of duodenum of BE and controls, nor in ex
vivo cultures of BE (Figure 6 C+D). We could clearly identify
positive and negative populations in IL-4
+ staining as T-cells from
one ex vivo culture of one a BE patient had small population of IL-
4
+-cells.
Similar expression patterns of a4 and b7 expressing
integrins on T-cells in BE and duodenum of BE patients
and controls
CD3
+-cells from BE had a similar expression of the gut homing
integrins a4 and b7 subunits (a4: 254635; b7 498642/mean
fluorescence (MFI) 6 SEM expressed in arbitrary units (AU)),
which was not different from CD3
+-cells from duodenum of BE
(a4: 165621 (AU), p=0.1 vs. BE; b7: 5836100 (AU), p=0.1 vs.
BE) (Figure 7 A+B). There was also no difference in a4 and b7
expression on CD3
+-cells between duodenum of BE and controls
(Figure 7 A+B). The proportion of CD3
+a4
+-cells was similar in ex
vivo cultures from BE (9661%), duodenum of BE (8969%) and
duodenum of controls (9563%) (Figure 7 C+D). The percentage
of CD3
+a4b7
+-cells was also similar in BE (6166%), duodenum of
BE (6569%) and duodenum of controls (6966%) (Figure 7 C+D).
MAdCAM-1mRNA expression in BE tissue is similar to
MAdCAM-1 expression in duodenal tissue
MAdCAM-1 (mucosal vascular addressin cell adhesion mole-
cule-1) is a ligand of a4b7 and is normally expressed on vascular
endothelium of the intestinal lamina propria [12]. Expression of
MAdCAM-1 in BE biopsies (0.0121660.004200, 2
2DCT6SEM,
corrected for GAPDH) was similar to expression of MAdCAM-1
in duodenal biopsies from BE patients (0.00705260.001244) and
controls (0.00866560.002790) (Figure 8).
Discussion
This is the first study showing that the T-cell composition in
tissue from BE (epithelium and lamina propria) is similar to what is
found in duodenal tissue from BE and controls. As the specialized
intestinal epithelium in BE esophagus is to a large extent similar to
epithelium normally found in the duodenum, this suggests that the
immune cell composition observed in BE is not an indication of an
active Th2 type inflammation, as has been suggested before [7,11],
but rather a consequence of metaplastic intestinal-type changes
that have occurred in BE.
The morphology of eosinophils in BE and duodenum [16,17]
exhibited a similar non-polarized, not-activated phenotype, which
is in contrast to eosinophils found in allergic disorders that are
polarized with the presence of free granules [18,19]. This finding is
Figure 6. Absence of IL-4 positive lymphocytes in BE cultures determined by intracellular FACS-staining. (1) Intracellular staining
for IFN-c and IL-4. Intracellular staining for IFN-c and IL-4 in T-cells was determined after stimulation with PMA (20 ng/ml) and ionomycin (1 mM) for
6 hrs. Hereafter, CD4
+ and CD8
+ cells from ex-vivo cultures of BE and duodenum from BE (DUO BE) and duodenum from controls (DUO control) were
analysed. Each bar represents mean value6SEM of the percentage of IFN-c cells inside CD3
+CD4
+-population (panel A), percentage of IFN-c cells
inside CD3
+CD8
+-population (panel B), percentage of IL-4 cells inside CD3
+CD4
+-population (panel C) and percentage of IL-4 cells inside CD3
+CD8
+-
population (panel D) (black bar: DUO control, dark grey bar: DUO BE, light grey bar: BE) (ns not significant) (BE, n=6,DUO BE, n=5, DUO control,
n=4). (2) Representative flowcytometry plots for IFN-c and IL-4 Representative flowcytometry plots of a representative staining of
lymphocytes from a duodenal culture ex vivo. Gates for CD4 and CD8 were set and positive cells for IL-4 and IFN-c were determined.
doi:10.1371/journal.pone.0033899.g006
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e33899the first indication that immune cells in BE are similar to those
normally found in intestinal tissue and that their presence is likely
not to be a consequence of inflammation. The observed slight
difference in numbers of eosinophils in BE and duodenum may be
explained by an aberrant intestinal microenvironment and/or a
the known less well developed vasculature in BE [20,21].
The high numbers of lymphocytes in BE were previously
interpreted as evidence of an inflammatory response [7,11].
However, little data are available regarding the specific pheno-
types of these T-cells because of the limited analytic power of IHC
to do this. Therefore, we applied a novel technique to expand ex
vivo T-cells to analyze T-cell phenotypes by multicolor FACS
analysis. Comparing this technique with IHC stainings showed
similar numbers of CD3
+/CD4
+ and CD3
+/CD8
+-cells (Figures 2
and 3).
In our study, similarly high percentages of memory CD4
+-cells
were observed in ex vivo cultures of duodenum and BE. It is known
that a healthy duodenum has abundant lymphocytes [22]. The
homing of these cells to this tissue is mediated by a large repertoire
of gut homing signals such as specific chemokines and chemokine
receptors [23]. This coincides with the proximity of mesenteric
lymph nodes and Peyer’s patches [24–26]. The absolute numbers
of lymphocytes in BE were lower than found in the duodenum.
The underlying mechanism remains to be elucidated, but
structural differences between BE and duodenal tissue might well
be involved, for example, as suggested above, a more extensive
vasculature in the duodenum compared to BE tissue that may
facilitate lymphocyte homing to intestinal tissue [16,20]. In
addition, homing of T-cells from Peyer’s patches towards the
submucosa may increase the numbers of T-cells found in the
duodenum [12,23].
Despite the 2.5 fold difference in absolute numbers, the relative
numbers of CD3
+/CD4
+ and CD3
+/CD8
+-cells in BE were
similar as found in duodenum (Figure 2). Although the high
number of CD3
+/CD4
+ does not rule out the presence of
inflammation, these findings suggest that these immune cells are at
least partly present in BE tissue due to homing signals normally
found in the gut rather than inflammatory signals. In contrast to
this view, previous studies have suggested that BE is associated
with a Th2 inflammatory response based on the presence of
mRNA for IL-4 and some IL-4 positive cells in IHC analysis
[7,11,27]. In contrast, intracellular stainings for IFN-c and IL-4 in
our T-cell cultures did not show a significant expression of IL-4 in
either CD4
+ or CD8
+-T-cells from BE cultures (Figure 6). In fact,
a high percentage of IFN-c-producing lymphocytes (both CD4
and CD8, see Figure 6) was found in both BE and duodenal tissue.
Other studies have also reported the production of IFN-c by
lymphocytes obtained from healthy duodenum [28]. This is a
further indication that the IFN-c signal in BE is probably caused
by homeostatic signals normally present in intestinal tissue rather
than an inflammatory process.
Granzyme B
+ CD8
+-cells are effector cells in viral infections and
cancer immunology [29,30]. Our results showed similar propor-
tions of Granzyme B
+CD8
+- cells in BE and in duodenal cultures
from BE and controls (Figure 5) as has previously been reported
for the duodenum; however, were lower than found in duodenal
inflammatory disease [22]. These findings are further supportive of
gut homing signals for T-cells in BE tissue (Figure 5).
The lymphocyte surface integrin CD103/beta7 (aEb7) recog-
nises epithelial cell E-cadherins involved in lymphocyte/epithelial
cell interactions [31] and is associated with T-cells with an
immunosuppressive phenotype [32–35]. Epithelial derived TGF-b
controls the expression of this integrin [15]. The percentage of
CD4
+CD103
+-cells was similar in BE and duodenum from BE
patients and controls (Figure 5). The relative deficit of
CD4
+CD103
+-cells in BE and intestine [36] may well reflect a
gut homing mechanism of these cells. Interestingly, BE has been
reported to be low in TGF-b and SMAD4 expression, particularly
when compared with normal squamous epithelium [37]. This
might well explain the low proportions of CD4
+/CD103
+-T-cells.
In contrast, healthy duodenal tissue is associated with a high
expression of TGF-b [38]. As this latter study did not compare
TGF-b expression between BE tissue and healthy intestinal-like
tissue no solid conclusions can be drawn with regard to TGF-b
function in BE.
Finally, our hypothesis is supported by the expression of the
intestinal homing integrin a4b7 on T-cells in BE which was similar
to that found on the intestinal T-cells from the duodenum
(Figure 7). Expression of the ligand for a4b7, MAdCAM-1 was
also similar in BE tissue and duodenal tissue. This provides the
conditions for lymphocyte arrest and trans-endothelial migration
to BE tissue by a mechanism normally operational during
homeostatic homing to intestinal tissue (Figure 8) [12]. The
question then arises what the consequences are of the presence of
‘‘intestinal’’ lymphocytes in BE tissue. This is currently unknown
Figure 7. Comparable integrin expression on T-cells from BE and duodenal tissue. The expression was analysed of a4 (panel A) and b7
(panel B) (arbitrary units, mean fluorescence) by CD3
+ cells in ex vivo cultures of BE and duodenum of BE patients (DUO BE) and controls (DUO
control) (black bar: DUO control, dark grey bar: DUO BE, light grey bar: BE). Also, the percentages of CD3
+a4
+-cells (panel C) and CD3
+a4b7
+-T-cells
(panel D) of the CD3
+-population in ex-vivo cultures of BE and duodenum from both groups were determined (ns not significant). There was no
difference in expression of a4 and b7 and percentage of a4
+ and a4
+b7
+ cells between duodenum of BE patients (DUO BE, n=7) and duodenum of
controls (DUO control) (n=5).
doi:10.1371/journal.pone.0033899.g007
Figure 8. MAdCAM-1 mRNA expression is similar in BE and
duodenal tissue from BE patients and controls. Real-time
quantitative polymerase chain reaction RNA assays were performed
on total BE biopsies (BE, n=12), duodenal biopsies from BE patients
(DUO BE, n=10) and duodenal biopsies from controls (DUO controls,
n=5) (black bar: DUO control, dark grey bar: DUO BE, light grey bar: BE).
Expression of MAdCAM-1, corrected for GAPDH, 2
2DCT6SEM, is
represented on the y-axis (ns: not significant).
doi:10.1371/journal.pone.0033899.g008
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esophagus is associated with an increased risk of adenocarcinoma,
while the malignant potential of duodenal tissue is low to almost
not existent. As we hypothesize that the immunologic environment
in BE is similar to that found in duodenal tissue, we speculate that
the microenvironment (reflux of gastric contents) in Barrett’s
esophagus plays a causative role in the increased risk of neoplastic
behaviour of this tissue.
This study is limited by the small size of the available biopsy
samples taken during routine endoscopic examinations of our
patients. Direct isolation of lymphocytes from these biopsies by
collagenase treatment resulted in low numbers of cells, which were
only sufficient for a single cell surface staining (intracellular
staining was not possible). In order to allow a more detailed
phenotypic characterization of the T-cells the immune cells
present in these biopsy samples were expanded by in vitro culture.
The main concern in the interpretation of the analysis of the ex vivo
expanded cell populations is in a putative skewing of the T-cells
during 14 days of culture. This method of ex vivo T-cell expansion
has, however, been extensively validated for T-cells from skin
tissues in which it was shown that both the chemokine receptors
and homing properties of the cells remained intact [14]. In this
study, we validated this method for BE by comparing the
phenotype of ex vivo expanded T-cells with that of cells isolated
directly from the BE biopsy by collagenase treatment. The
proportion of CD3
+/CD4
+ cells after 14 days of culture of BE
biopsies was similar to that found in collagenated BE biopsies
(Figure 3A). Moreover, the immunohistochemical analysis of
stained tissue sections confirmed the predominant presence of
CD3
+/CD4
+ cells in BE and duodenal tissue. A drawback of the
tissue staining was that CD4
+ cells comprise more than T-cells. We
therefore calculated the number of CD4
+ T-cells by subtracting
the number of CD8
+ T-cells from the CD3
+ count. CD3
+ cells can
also include natural-killer cells, but it is accepted to disregard
them, as they have been shown to comprise only 0.34% of the total
CD3
+ population in the duodenum [39]. Also, no CD3
+CD16
+
cells were seen in ex vivo cultures and collagenated biopsies from
duodenum and BE.
In conclusion, the composition of immune cells in BE tissue was
very similar to that found in normal, non-inflamed duodenal
tissue. In addition, the lymphocytes and eosinophils observed in
BE tissue were also not different in characteristics compared to
those in normal non-inflamed duodenal tissue. The expression of
the adhesion molecule MAdCAM-1 both in BE and duodenal
tissues supports the hypothesis that the inflammatory cell
composition in BE is not characterized by an active inflammatory
process, but rather by a change in the immune composition driven
by an altered homing due to the metaplastic changes in BE. This
suggests that the influx of inflammatory cells during the metaplasia
to BE is not mainly caused by an inflammatory process but in fact
is the consequence of alterations due to the metaplastic tissue more
resembling duodenal tissue. Further studies on the role of these
‘‘intestinal’’ lymphocytes in BE may result in a better understand-
ing of the pathogenesis and/or prognosis of BE.
Materials and Methods
Patient characteristics
Fifty-nine patients were included in our study. Of these, 41
patients had BE, as defined by the presence of specialised intestinal
metaplasia (IM) containing goblet cells in at least one of the
biopsies. Eleven patients were excluded from the BE group due to
the presence of macroscopic esophagitis (ulcers and erosions)
proximal to the Barrett’s segment (n=1), BE segments being
smaller then C0M2 because of the risk of biopsying squamous
esophageal epithelium or gastric tissue instead of BE tissue (n=8)
and 3) and insufficient cells to perform FACS analysis (n=2) [40].
This resulted in 31 BE patients and 18 age-matched controls that
could be included in our study (for demographic data see Table 1).
Controls were patients, who underwent upper endoscopy for
upper gastrointestinal (GI) symptoms other than gastroesophageal
reflux disease (GERD) symptoms and had no previous history of
GERD and immune-associated disorders like celiac disease.
Symptoms were evaluated by a standardised questionnaire, which
needed to be negative for GERD symptoms. Controls were also
not allowed to be known with immune-associated disorders. Of 12
included BE patients, biopsies were taken from BE and duodenum
for FCS-analysis and immunohistochemical staining. Paired
biopsies were taken from each section, with one biopsy being
used for T-cell expansion cultures and one for immunohistochem-
ical stainings. From 13 controls, biopsies were taken from
duodenum (no endoscopic abnormalities) and used for FACS-
analysis and immunohistochemical staining. Of 5 BE patients
paired biopsies from BE tissues were used for validation of the ex
vivo culture: one biopsy was taken for treatment with collagenase
and one biopsy was used for ex vivo culture. Of 14 BE patients,
biopsies were taken from BE and duodenum for mRNA isolation
and QT-PCR. From 5 controls duodenal biopsies were used for
mRNA isolation.
The study was approved by Medical Ethical Committee of the
University Medical Center Utrecht and written informed consent
was obtained from all patients and controls.
Immunohistochemistry
Biopsies were fixed in formalin and embedded in paraffin as
described previously 7. In short, sections (4 mm) were deparaffi-
nised and endogenous peroxidase was blocked by using 0.3%
H2O2-blocking buffer (Sigma, St. Louise, MO, USA). For staining
with anti-CD8, cytotoxic T-cell marker (clone c8/144B, DAKO,
Glostrup, Denmark), anti-CD3 and pan-T-cell marker (polyclonal
rabbit, DAKO), antigen retrieval was performed in 10 mM
monocitric acid (pH=6) at 100uC for 20 min. For staining with
anti-CD4, a T-helper cell marker (clone 4B12, MonosanH, The
Netherlands), antigen retrieval was performed in 10 mM Tris and
1 mM ethylenediamine tetraaceticacid (pH=8) at 100uC for
20 min, while for staining with anti-MBP (Major Basic Protein)
(clone BMK13, AbD Serotec, Dusseldorf, Germany), antigen
retrieval was performed by treatment with pepsin in HCL-buffer
(pH=2) for 15 minutes at 37.5uC. The sections were stained with
primary antibodies directed against cytotoxic T cells (CD8, 4 mg/
L), T helper cells (CD4, 1:100), total lymphocytes (CD3, 6 mg/L),
and eosinophils (anti-MBP; 1:4000, 50 ng/L) for 1 h at room
Table 1. Demographic data of patients with Barrett’s
esophagus (BE) and controls included in this study.
BE patients Controls
Number of patients 31 18
Mean age (6SD) 59612 55617
Gender (% males) 68% 19%
Presence of low grade dysplasia 19% 0
PPI use 97% 23%
Hiatal Hernia 81% 16%
doi:10.1371/journal.pone.0033899.t001
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(clone S0721, Vector, CA, USA, 3 mg/L) or biotinylated goat
anti-rabbit antibody (clone R0919, Vector, CA, USA, 3 mg/L)
was added, followed by incubation with streptavidin HRP (1:1000,
IM 0309, Beckman Coulter, Marseille, France), or by incubation
with polyclonal anti-mouse, -rabbit, or -rat Powervision HRP
(Immunologic, Duiven, The Netherlands). A brown color was
developed using di-amino-benzidine substrate (Sigma) and bright
DAB-substrate kit (BS04-110, Immunologic). The positive controls
for anti-CD3, -CD4 and -CD8 (tonsil tissue) and anti-MBP
stainings (nasal polyp tissue) were taken with each staining.
Negative controls for the immunohistochemical stainings were
obtained by omitting primary antibody from the staining protocol.
Quantification of stained cells was performed by a computer
assisted video microscopy system (Quantimet 570C, DXMRE
microscope, PL fluotar 406 power objective lens (Leica, Heidel-
berg, Germany)) with custom made software which aids in the
counting of cells and expresses the data as cells per mm
2 per area
measured. The number of cells per mm
2 was determined in
specialized intestinal epithelium (SIE) and lamina propria (LP) of
BE and epithelium and LP of duodenum. When several biopsies
from the same patient were present on a slide, the average of the
values of all biopsies on each slide was calculated irrespective of
the size of the biopsy.
Ex vivo expansion of T-cells
Expansion of T-cells was performed according to a previously
described method with small modifications [14]. In short, fresh
biopsies were washed three times in IMDM medium (Lonza,
Basel, Switzerland,) with 10 m amphotericin (FungizoneH, Gib-
co
TM, Invitrogen, Camarillo, CA, USA). Cellfoam matrices
((9 mm69m m 61.5 mm; Cellsciences Pte Ltd, Singapore) were
autoclaved, then incubated in 100 mg/ml rat tail collagen I (BD
Biosciences, Bedford, MA) in phosphate-buffered saline (PBS) for
30 minutes at 37uC, followed by two rinses in PBS. Biopsies were
placed on the matrix in a T-cell culture medium (IMDM, 14.2 M
b-mercaptoethanol, penicillin, streptomycin, heat inactivated
foetal calf serum (8%, Gibco
TM), 1 mM Hepes, and 0.29 mg/ml
freshly added L-glutamine (Gibco
TM), with 10 units of IL-2 (BD
Biosciences). Clark et al. previously showed that IL-2 alone
increased proliferation by 5-fold while cells preserved their homing
phenotype [14]. Cells were harvested after 1, 2 and 3 weeks of
culturing for staining and analysis by flow cytometry (FACS)
(FACScalibur, Becton&Dickinson, Mountain View, CA, USA).
Staining of cell surface markers and analysis by FACS
The immunophenotyping of lymphocytes was performed on
day 14 of culturing, as we determined in an earlier pilot study that
the number of cells as measured by FACS was only sufficient after
at least 2 weeks of culturing (results not shown). Cells (0.5610
3–
10
5) were washed with PBS supplemented with trisodium citrate
(0.4% w/v, pH 7.4) and human pasteurised plasma solution (4 g/
L; PBS2+) and subsequently incubated for 30 minutes on ice with
directly labelled antibodies according to the instructions of the
manufacturer. After washing with PBS2+, cells were resuspended
in the same buffer and analysed by FACS.
For FACS stainings, the following antibodies were used: mAb
CD3-FITC (clone sk7, 1:20, BD Biosciences), CD3-PE (clone sk7,
1:20, BD Biosciences), CD8-APC (clone SK1, 1:100, BD
Biosciences), CD8-PerCP(clone SK1, 1:20, BD Biosciences),
CD4-PerCP (clone L200, 1:20, BD Pharmingen, San Diego,
CA, USA), CD45RO-PE, memory T-cell marker (clone UCH1,
1:25, BD Biosciences), CD45 RA-FITC, naı ¨ve T-cell marker
(clone L48, 1:25, BD Biosciences), CD103 (aE)-FITC, intraepi-
thelial T-cell marker (Clone Ber-ACT8, 1:20, BD Pharmingen),
CD49d (a4)-PE (clone 9F10, 1:20, eBioscience, San Diego, CA,
USA), and anti-b7-PerCP (clone FIB27, BioLegend, San Diego,
CA, USA). Positive populations for CD4, CD8, CD45RO, CD94
and NKg2a were identified by testing the specific antibodies
together with the appropriate isotype control on PBMC’s. Isotype
controls were not taken along with the experiments of ex vivo
cultured cells due to the small number of cells available.
Intracellular granzyme B staining for FACS analysis
First, 2610
3–10
5 cells were stained with the cell surface markers
CD103 (aE)-FITC, Clone Ber-ACT8, BD Pharmingen) and CD8-
PerCP (clone SK1, BD Biosciences). Then, cells were fixed in a
fixation/permeabilization solution (eBioscience) for 10 minutes.
After washing in a permeabilization solution (eBioscience), cells
were incubated with mAb anti-granzyme B-PE (2 mg/ml, clone
CLB-GB11, Sanquin, Amsterdam, The Netherlands) in the
permeabilization solution (eBioscience) for 30 minutes. Cells were
washed with PBS2+ and then FACS analysis was performed.
Distinct populations were identified in lymphocytes from Barrett
tissue and duodenal tissue. This enabled us to clearly distinguish
populations with a high granzyme B expression level.
Intracellular staining for IFN-c and IL-4
For intracellular cytokine staining, 3-week cultures were chosen
due to the requirement of a relatively high number of cells. Cells
(2610
3–10
5) in culture were stimulated for 6 hours with 3 mg/ml
ionomycin (Invitrogen) and 20 ng/ml phorbol 12-myristate 13-
acetate (ICN Biomedicals Inc, Aurora, OH, USA). One hour after
the start of the stimulation brefeldin-A (Invitrogen) was added to
stop the exocytosis of the cytokines. Cells were stained with the cell
surface markers CD4-PerCp (1:20, clone L200, BD Pharmingen)
and CD8-APC (1:100 clone SK1, BD Biosciences). Then, cells
were fixed in 4% paraformaldehyde for 20 minutes on ice. Cells
were permeabilised by 15-minutes incubation on ice in Perm/
Wash Buffer (BD Biosciences). The next step was to incubate the
cells 50 ml Perm/Wash buffer containing anti-IFN-c-FITC (clone
25723.110, 1:20) and IL-4 (clone 3010.211, 1:20) (BD Biosciences)
for 30 minutes on ice. The next step was to wash the cells twice in
Perm/Wash buffer, after which the cells were taken up in PBS/
0.1% sodium azide for FACS analysis.
Treatment of biopsies with collagenase
Fresh biopsies were treated with collagenase III, 1 mg/ml
(Worthington, Freehold, NJ, USA) for 1 hour in RPMI medium at
37uC and put through a cell strainer (BD Falcon
TM, BD Drive, NJ,
USA). Then, the cells were washed with PBS2+, stained with the
fluorescent labels CD103 (aE)-FITC, CD3-PE CD4-PerCP, CD8-
APC and analysed with FACS.
RT-PCR RNA analysis
RNA purified from esophageal biopsies was used for real-time
PCR assays. RNA was isolated from from esophageal and
duodenal biopsies using the RNeasy Mini Kit (Qiagen, Valencia,
CA), according to the manufacturer’s instructions. For cDNA
synthesis, 1 mg total RNA was transcribed into cDNA with the
cDNA transcription reagents (Bio-Rad, Hercules, CA, USA) using
oligo(dT) and random primers according to manufacturer’s
instructions. Amplification and real time detection of PCR
products with SYBR green was performed in a MyiQ Real-Time
PCR detection system (Bio-Rad, Hercules, CA, USA) under the
following conditions: 3 minutes at 95uC and 40 cycles of 30 sec at
95uC, 30 sec at 60uC and 30 sec at 72uC. The results represent
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gene GAPDH and plotted as fold change. Primers used were
GAPDH F: 59-agaaggctggggctcattt-93, GAPDH R: 59-gaggcattgct-
gatgatcttg-93, (MAdCAM-1 F: 59-acgcagggagaagtgatcccaaca-93,
MAdCAM-1 R: 59-tttccagaggtgatacgtgggcaa-93. GAPDH and
MAdCAM-1 primers were purchased from Sigma Aldrich, St.
Louis, USA. The expression level of a gene in a given sample
was represented as 2
2DCT, where DCT=[CT(experimental)]2
[CT(housekeeping)]. PCR assays were performed in duplicate.
Statistical analyses
All continuous variables were statistically analysed with one-way
analysis of variance non-parametric test, using Kruskal-Wallis test
used to compare the three groups: BE tissue, duodenum of BE
patients and duodenum of controls. A two-sided p-value ,0.05
was considered to be statistically significant. All statistical analyses
were conducted using GraphPad Prism 5 (La Jolla, CA, USA).
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